RAC1 and diabetes mellitus: These in vivo and in vitro observations demonstrated Rac1 depletion benefited diabetic podocytes through a major and early attenuation on plasticity of podocyte cytoskeleton via preserving SDs and FPs both structurally and functionally in the challenge of diabetes.